All stock lists
ICL Group Ltd. (New York Stock Exchange:ICL)
IL · Delayed Price · Currency is USD
Also listed: ICL.TABasic Materials · Agricultural Inputs
4.68+0.00 (+0.00%)
Market cap
$6.04B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 22, 2005
Website
Insider Score
––Not scored
ICL Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From ICL’s reported statements · Q2 2026 (trailing 12 months)
Profitability12 / 20
Profitable, but on a thin margin.
- Revenue
- $7.71B
- Net income
- $305.0M
- Net margin
- 4.0%
Leverage10 / 20
A manageable debt load.
- Total debt
- $3.30B
- Cash
- $496.0M
- Net debt / EBITDA
- 1.92x
Liquidity14 / 20
Comfortably covers what is due within a year.
- Current assets
- $4.50B
- Current liabilities
- $2.84B
- Current ratio
- 1.58
Cash generation14 / 20
The business funds itself from operations.
- Operating cash flow
- $1.08B
- Free cash flow
- $291.0M
- FCF margin
- 3.8%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 1290.7M
- Share growth (1y)
- -0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ICL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 2.13 B | 2.02 B | 1.70 B | 1.85 B | 1.83 B | 1.77 B |
| Revenue Growth (YoY) | 16.54 % | 14.49 % | 6.25 % | 5.70 % | 4.57 % | 1.84 % |
| Cost of Revenue | 1.47 B | 1.40 B | 1.23 B | 1.25 B | 1.28 B | 1.21 B |
| Gross Profit | 664.00 M | 626.00 M | 468.00 M | 604.00 M | 554.00 M | 560.00 M |
| SG&A Expense | 383.00 M | 377.00 M | 359.00 M | 363.00 M | 346.00 M | 345.00 M |
| R&D Expense | 14.00 M | 15.00 M | 17.00 M | 16.00 M | 19.00 M | 18.00 M |
| Operating Expenses | 397.00 M | 391.00 M | 369.00 M | 374.00 M | 365.00 M | 375.00 M |
| Operating Income | 267.00 M | 235.00 M | 99.00 M | 230.00 M | 189.00 M | 185.00 M |
| Pretax Income | 224.00 M | 193.00 M | -61.00 M | 186.00 M | 168.00 M | 148.00 M |
| Tax Provision | 72.00 M | 53.00 M | 2.00 M | 57.00 M | 60.00 M | 42.00 M |
| Net Income | 137.00 M | 126.00 M | -73.00 M | 115.00 M | 93.00 M | 91.00 M |
| EPS (Basic) | 0.11 | 0.10 | -0.06 | 0.09 | 0.07 | 0.07 |
| EPS (Diluted) | 0.11 | 0.10 | -0.06 | 0.09 | 0.07 | 0.07 |
| Shares Outstanding | 1.29 B | 1.29 B | 1.29 B | 1.29 B | 1.29 B | 1.29 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.